CClinicalTrials.gg
CompletedNCT04301401VAGIBIOTEUpdated Jan 13, 2026

Assessment of Changes in Vaginal Microbiota Profiles Before and After Vaginal Urogynecologic Surgery

An interventional study of Vaginal swabs and Stool samples in Gynecological Surgery, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-13.

Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Several studies have shown interactions between vaginal microbiota and post-surgical evolution. A study conducted by our team showed a tendency for patients with complications to have a greater diversity of vaginal microbiota. The main objective of the proposed study will therefore be to evaluate the vaginal, urinary and digestive microbiota modifications during and after vaginal surgery and to correlate them with the symptoms of the urogynecological sphere.

Read the detailed description

In gynecological surgery, surgical site infections are a common complication. Gynecological surgery and, more specifically, vaginal surgery leads to a high risk of infection not only due to its " clean-contaminated " nature related to the proximity of the vagina but also due to the use of a transvaginal mesh or suburetal sling. The germs most commonly found at the origin of a surgical site infection are germs forming part of the vaginal flora.

Furthermore, in the field of pelvic organ prolapse surgery, certain specific complications such as mesh retraction and mesh exposure may be related to infection due to bacterial colonisation.

The vaginal ecosystem contains a large quantity of bacteria, the commonest of which are lactobacilli. This ecosystem varies in women depending on their sexuality, hormonal impregnation, tobacco consumption or hygiene.It has been demonstrated that the microbiota can be divided into 7 classes depending on the predominant types of germ. It has also been shown that an imbalance in vaginal flora could be responsible for infections of the upper genital tract, obstetric complications or even the transmission of sexually transmissible diseases.

Several studies have shown interactions between the microbiota and post surgical evolution. A recent study carried out at the Gynecology and Obstetrics department of Nîmes University Hospital (Veit Rubin et al, NAU 2019) also investigated the relationship between vaginal microbiota and the onset of postoperative complications in transvaginal mesh surgery. This retrospective study also found that patients with complications tended to have a greater diversity of microbiota. Furthermore, certain species of bacteria (Veillonella spp) seemed to be commoner in patients with complications. However, this was a low-powered retrospective study with few participants and the results therefore need to be confirmed.

Our hypothesis is that the vaginal microbiota may be modified by a surgical act with a vaginal approach. There are very few studies on vaginal microbiota and so far no studies have evaluated the potential impact of a transvaginal surgery on vaginal microbiota.

Our study may help to better understand the relationship between the vaginal microbiota and the postoperative evolution of patients.These possible modifications in vaginal microbiota might be predictive of the symptomatology of patients benefitting from transvaginal surgery and play a role in the the post-operative evolution of these patients.

02

Conditions studied

  • Gynecological Surgery

Keywords

  • Microbiota
  • vagina
  • prolapse
  • transvaginal surgery
  • surgical site infection
03

In context

Prolapse

676 studies on the registry are indexed under Prolapse; 79 are open to participants now.

This study's enrollment of 60 is below the median of 74 across 435 interventional studies indexed under Prolapse.

Browse Prolapse studies →

Lead sponsor

Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 587 studies on the registry; 96 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • All Caucasian menopausal women (not taking hormone substitutes)
  • Due to undergo transvaginal surgery (as a cure for pelvic organ prolapse or stress urinary incontinence surgery) from the Gynecology departments of Nantes and Nîmes University Hospitals.
  • Patients must be covered by a health insurance policy
  • Patients must have given written, informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients on recent (\<1 month) immunosuppressive therapy,
  • Patients with ongoing antibiotic therapy,
  • Patients with chronic vaginosis,
  • Patients on hormone replacement therapy
  • Patients who have had previous transvaginal mesh surgery.
  • Patients taking part in another category 1 study for research involving human subjects.
  • Patients in an exclusion period determined by another study
  • Patients under court custody, guardianship or curatorship
  • Patients for whom it has been impossible to give clear information
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Patients being evaluated for changes in microbiota

    Patients being evaluated for changes in vaginal microbiota following transvaginal surgery.

    Other: Vaginal swabs · Other: Stool samples · Other: Urine samples

Interventions

  • OtherVaginal swabs

    On the day of the surgical intervention, vaginal swabs will be taken at various stages of surgery: before vaginal disinfection/draping, directly after disinfection/draping, 1 hour after disinfection, 6 weeks after surgery and 12 months after surgery.

  • OtherStool samples

    Stool samples will also be taken (and collected in a pot devoted to coproculture with an airtight opaque bag given to the patient) at the inclusion visit on the day before surgery and also 6 weeks after surgery (in a second pot with an airtight opaque bag given to the patient at the time of being discharged).

  • OtherUrine samples

    Urine samples will also be taken before surgery and 6 weeks after surgery.

06

What researchers measure

Primary outcomes

  1. Classes of vaginal flora before surgery

    A vaginal swab will be taken before surgery and the sample will be analyzed by DNA sequencing in order to classify the microbiota into community state types.

    Time frame: Day 1

  2. Classes of vaginal flora 6 weeks after surgery

    A vaginal swab will be taken 6 weeks after surgery and the sample will be analyzed by DNA sequencing in order to classify the microbiota into community state types.

    Time frame: Day 42

Secondary outcomes

  1. Classes of vaginal flora 12 mois after surgery

    A vaginal swab will be taken 12 months after surgery and the sample will be analyzed by DNA sequencing in order to classify the microbiota into community state types.

    Time frame: Month 12

  2. Alphadiversity of vaginal flora before preparation for surgery measured with the Shannon index

    A vaginal swab will be taken before any preparation for surgery has begun and the alphadiversity of the microbiota will be measured according to the Shannon index in Taxonomic Operational Units

    Time frame: Day 1

  3. Betadiversity of vaginal flora before preparation for surgery measured with the Bray-Curtis index

    A vaginal swab will be taken before any preparation for surgery has begun and the betadiversity of the microbiota will be measured according to the Bray-Curtis index in Taxonomic Operational Units

    Time frame: Day 1

  4. Alphadiversity of vaginal flora directly after disinfection and draping, measured with the Shannon index

    A vaginal swab will be taken directly after disinfection and draping and the alphadiversity of the microbiota will be measured according to the Shannon index in Taxonomic Operational Units.

    Time frame: Day 1

  5. Betadiversity of vaginal flora directly after disinfection and draping, measured with the Bray-Curtis index

    A vaginal swab will be taken directly after disinfection and draping and the betadiversity of the microbiota will be measured according to the Bray-Curtis index in Taxonomic Operational Units.

    Time frame: Day 1

  6. Alphadiversity of vaginal flora one hour after disinfection and draping, measured with the Shannon index

    A vaginal swab will be taken one hour after disinfection and draping and the alphadiversity of the microbiota will be measured according to the Shannon index in Taxonomic Operational Units.

    Time frame: Day 1

  7. Betadiversity of vaginal flora one hour after disinfection and draping, measured with the Bray-Curtis index

    A vaginal swab will be taken one hour after disinfection and draping and the betadiversity of the microbiota will be measured according to the Bray-Curtis index in Taxonomic Operational Units.

    Time frame: Day 1

  8. Alphadiversity of vaginal flora six weeks after surgery, measured with the Shannon index

    A vaginal swab will be taken six weeks after surgery and the alphadiversity of the microbiota will be measured according to the Shannon index in Taxonomic Operational Units.

    Time frame: Day 42

  9. Betadiversity of vaginal flora six weeks after surgery, measured with the Bray-Curtis index

    A vaginal swab will be taken six weeks after surgery and the betadiversity of the microbiota will be measured according to the Bray-Curtis index in Taxonomic Operational Units.

    Time frame: Day 42

  10. Alphadiversity of vaginal flora twelve months after surgery, measured with the Shannon index

    A vaginal swab will be taken twelve months after surgery and the alphadiversity of the microbiota will be measured according to the Shannon index in Taxonomic Operational Units.

    Time frame: Month 12

  11. Betadiversity of vaginal flora twelve months after surgery, measured with the Bray-Curtis index

    A vaginal swab will be taken twelve months after surgery and the betadiversity of the microbiota will be measured according to the Bray-Curtis index in Taxonomic Operational Units.

    Time frame: Month 12

  12. Prolapse. Feeling a bulge six weeks after surgery

    Yes/No. If present, this will be classified according to the International Continence Society-International Urogynecological Association classification

    Time frame: Day 42

  13. Prolapse. Feeling a bulge twelve months after surgery

    Yes/No. If present, this will be classified according to the International Continence Society-International Urogynecological Association classification

    Time frame: Month 12

  14. Dyspareunia six weeks after surgery

    Yes/no. If present, this will be rated according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Day 42

  15. Dyspareunia 12 months after surgery

    Yes/No. If present, this will be rated according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Month 12

  16. Pain six weeks after surgery

    The patient will be asked to evaluate pain according to a visual analogue scale ranging from 0 (no pain) to 10 (extremely painful).

    Time frame: Day 42

  17. Pain 12 months after surgery

    The patient will be asked to evaluate pain according to a visual analogue scale ranging from 0 (no pain) to 10 (extremely painful).

    Time frame: Month 12

  18. Urinary incontinence upon effort six weeks after surgery

    Yes/No. If present, this will be rated according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Day 42

  19. Urinary incontinence upon effort 12 months after surgery

    Yes/No.If present, this will be classified according to the International Continence Society-International Urogynecological Association classification

    Time frame: Month 12

  20. Need to urinate urgently six weeks after surgery

    Yes/No.If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Day 42

  21. Need to urinate urgently 12 months after surgery

    Yes/No.If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Month 12

  22. Dysuria 6 weeks after surgery

    Yes/No.If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Day 42

  23. Dysuria 12 months after surgery

    Yes/No.If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Month 12

  24. Constipation 6 weeks after surgery

    Yes/No. If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Day 42

  25. Constipation 12 months after surgery

    Yes/No. If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Month 12

  26. Anal incontinence 6 weeks after surgery

    Yes/No. If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Day 42

  27. Anal incontinence 12 months after surgery

    Yes/No. If present, this will be classified according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Month 12

  28. Presence or absence of complications 6 weeks after surgery

    Yes/No. If present, these will be rated according to the Clavien Dindo classification. The Clavien Dindo classification is a scale with grades ranging from 1 to 5 in which Grade 1 = any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside. Grade 5 = death of the patient.

    Time frame: Day 42

  29. Presence or absence of complications 12 months after surgery

    Yes/No. If present, these will be rated according to the Clavien Dindo classification.The Clavien Dindo classification is a scale with grades ranging from 1 to 5 in which Grade 1 = any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside. Grade 5 = death of the patient.

    Time frame: Month 12

  30. Presence or absence of complications related to a prosthesis 6 weeks after surgery

    Yes/No. If present, these will be rated according to the International Continence Society-International Urogynecological Association classification

    Time frame: Day 42

  31. Presence or absence of complications related to a prosthesis 12 months after surgery

    Yes/No. If present, these will be rated according to the International Continence Society-International Urogynecological Association classification.

    Time frame: Month 12

  32. Presence or absence of infection at the operating site 6 weeks after surgery

    Yes/No

    Time frame: Day 42

  33. Presence or absence of infection at the operating site 12 months after surgery

    Yes/No

    Time frame: Month 12

  34. Urine sample before surgery

    A urine sample will be collected from the patient before surgery and stored in a sterile pot at -80° at the Biological resource Centre at Nîmes or Nantes University Hospitals.

    Time frame: Day 1

  35. Urine sample after vaginal disinfection and surgical draping.

    A urine sample will be collected from the patient before surgery but after vaginal disinfection and surgical draping, and stored in a sterile pot at -80° at the Biological resource Centre at Nîmes or Nantes University Hospitals.

    Time frame: Day 1

  36. Urine sample 6 weeks after surgery six weeks after surgery

    A urine sample will be collected from the patient 6 weeks after surgery and stored in a sterile pot at -80° at the Biological resource Centre at Nîmes or Nantes University Hospitals.

    Time frame: Day 42

  37. Urine sample 12 months after surgery

    A urine sample will be collected from the patient 12 months after surgery and stored in a sterile pot at -80° at the Biological resource Centre at Nîmes or Nantes University Hospitals.

    Time frame: Month 12

  38. Stool sample before surgery

    The day before surgery, at the inclusion visit, a stool sample will be collected in a sterile pot and stored at -80° at the Biological resource Centre at Nîmes or Nantes University Hospitals.

    Time frame: Day 0

  39. Stool sample 6 weeks after surgery

    Six weeks after surgery, a stool sample will be collected in a sterile pot and stored at -80° at the Biological resource Centre at Nîmes or Nantes University Hospitals.

    Time frame: Day 42

07

Study locations

1 site
  • Centre Hospitalier Universitaire
    Nîmes, Gard 30000, France
08

References and documents

Publications

  • Zhang Y, Allegre L, Salipante F, Morsli M, Thubert T, Lavigne JP, Dunyach-Remy C, de Tayrac R. Impact of surgical field disinfection on vaginal microbiome in transvaginal urogynecological surgery: a prospective cohort study. Antimicrob Resist Infect Control. 2025 Aug 26;14(1):102. doi: 10.1186/s13756-025-01622-6. PubMed 40859385 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04301401
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Collaborators
Nantes University Hospital
Responsible party
Sponsor
First posted
Mar 10, 2020
Start date
Mar 1, 2020
Primary completion
Jan 18, 2023
Completion
Oct 10, 2023
Last update
Jan 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion